These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21601173)

  • 1. [Psoriasis and obesity: a review and practical recommendations].
    Farías MM; Serrano V; de la Cruz C
    Actas Dermosifiliogr; 2011 Sep; 102(7):505-9. PubMed ID: 21601173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis and the metabolic syndrome.
    Alsufyani MA; Golant AK; Lebwohl M
    Dermatol Ther; 2010; 23(2):137-43. PubMed ID: 20415820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation.
    Bremmer S; Van Voorhees AS; Hsu S; Korman NJ; Lebwohl MG; Young M; Bebo BF; Blauvelt A;
    J Am Acad Dermatol; 2010 Dec; 63(6):1058-69. PubMed ID: 20692722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidities in patients with psoriasis.
    Gottlieb AB; Dann F
    Am J Med; 2009 Dec; 122(12):1150.e1-9. PubMed ID: 19958894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review.
    Sterry W; Strober BE; Menter A;
    Br J Dermatol; 2007 Oct; 157(4):649-55. PubMed ID: 17627791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy.
    Bardazzi F; Balestri R; Baldi E; Antonucci A; De Tommaso S; Patrizi A
    Dermatol Ther; 2010; 23 Suppl 1():S14-9. PubMed ID: 20136916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and psoriasis: body weight and body mass index influence the response to biological treatment.
    Puig L
    J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1007-11. PubMed ID: 21492252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric bypass surgery improves psoriasis.
    Hossler EW; Maroon MS; Mowad CM
    J Am Acad Dermatol; 2011 Jul; 65(1):198-200. PubMed ID: 20655127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic inflammation in psoriasis and obesity: implications for therapy.
    Hamminga EA; van der Lely AJ; Neumann HA; Thio HB
    Med Hypotheses; 2006; 67(4):768-73. PubMed ID: 16781085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research in practice: the systemic aspects of psoriasis.
    Boehncke WH; Boehncke S
    J Dtsch Dermatol Ges; 2008 Aug; 6(8):622-5. PubMed ID: 18564207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis and body mass index.
    Hercogová J; Ricceri F; Tripo L; Lotti T; Prignano F
    Dermatol Ther; 2010; 23(2):152-4. PubMed ID: 20415822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis.
    Daudén E; Castañeda S; Suárez C; García-Campayo J; Blasco AJ; Aguilar MD; Ferrándiz C; Puig L; Sánchez-Carazo JL;
    J Eur Acad Dermatol Venereol; 2013 Nov; 27(11):1387-404. PubMed ID: 23134338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment goals in psoriasis.
    Reich K; Mrowietz U
    J Dtsch Dermatol Ges; 2007 Jul; 5(7):566-74. PubMed ID: 17610606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis comorbidities.
    Gottlieb AB; Chao C; Dann F
    J Dermatolog Treat; 2008; 19(1):5-21. PubMed ID: 18273720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis and Obesity.
    Jensen P; Skov L
    Dermatology; 2016; 232(6):633-639. PubMed ID: 28226326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe psoriasis: beyond the skin, what are the risks of not treating the disease?].
    Bessis D
    Ann Dermatol Venereol; 2008 Jul; 135 Suppl 5():S285-9. PubMed ID: 18721666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How should we manage patients with non-alcoholic fatty liver disease in 2007?
    Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome.
    Chen YJ; Wu CY; Shen JL; Chu SY; Chen CK; Chang YT; Chen CM
    Arch Dermatol; 2008 Dec; 144(12):1571-5. PubMed ID: 19075139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of obesity and smoking on psoriasis presentation and management.
    Herron MD; Hinckley M; Hoffman MS; Papenfuss J; Hansen CB; Callis KP; Krueger GG
    Arch Dermatol; 2005 Dec; 141(12):1527-34. PubMed ID: 16365253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between psoriasis and the metabolic syndrome. A cross-sectional study.
    Cohen AD; Sherf M; Vidavsky L; Vardy DA; Shapiro J; Meyerovitch J
    Dermatology; 2008; 216(2):152-5. PubMed ID: 18216477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.